THE USE OF DISEASE-MODIFYING THERAPIES IN MULTIPLE SCLEROSIS
Principles and Current Evidence
A Consensus Paper by the Multiple Sclerosis Coalition
Principles and Current Evidence
A Consensus Paper by the Multiple Sclerosis Coalition
ABSTRACT
Purpose: The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States.
Purpose: The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States.
Development Process: The original writing and development team comprised of professional staff representing the Coalition organizations (Rosalind Kalb, Kathleen Costello, June Halper, Lisa Skutnik and Robert Rapp) developed a draft for review and input by nine external reviewers (Brenda Banwell, Aliza BenZacharia, James Bowen, Bruce Cohen, Bruce Cree, Suhayl Dhib-Jalbut, Daniel Kantor, Flavia Nelson and Nancy Sicotte). The reviewers, selected for their experience and expertise in MS clinical care and research, were charged with ensuring the accuracy, completeness and fair balance of the content. The revised paper was then submitted for review by the medical advisors of the Coalition member organizations.
CLICK here to continue reading
——————————————————————–
This Article is Provided by: #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews